Lack of mutations in EGFR in gastroenteropancreatic neuroendocrine tumors

被引：19
作者：
Gilbert, JA [1 ]
Lloyd, RV [1 ]
Ames, MM [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN 55905 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 02期
关键词：
D O I：
10.1056/NEJM200507143530219
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：209 / 210
页数：2
相关论文
共 4 条
  • [1] A novel approach in the treatment of neuroendocrine gastrointestinal tumours.: Targeting the epidermal growth factor receptor by gefitinib (ZD1839)
    Höpfner, M
    Sutter, AP
    Gerst, B
    Zeitz, M
    Scherübl, H
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (09) : 1766 - 1775
  • [2] Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy
    Howe, MC
    Chapman, A
    Kerr, K
    Dougal, M
    Anderson, H
    Hasleton, PS
    [J]. HISTOPATHOLOGY, 2005, 46 (02) : 195 - 201
  • [3] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    Lynch, TJ
    Bell, DW
    Sordella, R
    Gurubhagavatula, S
    Okimoto, RA
    Brannigan, BW
    Harris, PL
    Haserlat, SM
    Supko, JG
    Haluska, FG
    Louis, DN
    Christiani, DC
    Settleman, J
    Haber, DA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2129 - 2139
  • [4] EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
    Paez, JG
    Jänne, PA
    Lee, JC
    Tracy, S
    Greulich, H
    Gabriel, S
    Herman, P
    Kaye, FJ
    Lindeman, N
    Boggon, TJ
    Naoki, K
    Sasaki, H
    Fujii, Y
    Eck, MJ
    Sellers, WR
    Johnson, BE
    Meyerson, M
    [J]. SCIENCE, 2004, 304 (5676) : 1497 - 1500
1